A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: AstraZeneca Clinical Study Information Center
- Phone Number: 1-877-240-9479
- Email: information.center@astrazeneca.com
Study Locations
-
-
-
Barretos, Brazil, 14784-400
- Not yet recruiting
- Research Site
-
Brasília, Brazil, 71625-009
- Not yet recruiting
- Research Site
-
Rio de Janeiro, Brazil, 22270-060
- Not yet recruiting
- Research Site
-
-
Ceará
-
Fortaleza, Ceará, Brazil, 60430-350
- Not yet recruiting
- Research Site
-
-
Paraná
-
Curitiba, Paraná, Brazil, 80030-480
- Recruiting
- Research Site
-
-
Rio Grande do Norte
-
Natal, Rio Grande do Norte, Brazil, 59020-035
- Not yet recruiting
- Research Site
-
-
Rio Grande do Sul
-
Porto Alegre, Rio Grande do Sul, Brazil, 90630-165
- Not yet recruiting
- Research Site
-
-
São Paulo
-
Campinas, São Paulo, Brazil, 13060-904
- Not yet recruiting
- Research Site
-
São José dos Campos, São Paulo, Brazil, 12243-280
- Not yet recruiting
- Research Site
-
São Paulo, São Paulo, Brazil, 01228-200
- Not yet recruiting
- Research Site
-
São Paulo, São Paulo, Brazil, 04012-180
- Not yet recruiting
- Research Site
-
-
-
-
-
Budapest, Hungary, 1138
- Not yet recruiting
- Research Site
-
Budapest, Hungary, 1132
- Recruiting
- Research Site
-
Budapest, Hungary, 1024
- Recruiting
- Research Site
-
Salgótarján, Hungary, 3100
- Not yet recruiting
- Research Site
-
Szolnok, Hungary, 5000
- Not yet recruiting
- Research Site
-
Zalaegerszeg, Hungary, 8900
- Recruiting
- Research Site
-
-
HU
-
Budapest, HU, Hungary, 1036
- Recruiting
- Research Site
-
Budapest, HU, Hungary, 1089
- Recruiting
- Research Site
-
Debrecen, HU, Hungary, 4032
- Not yet recruiting
- Research Site
-
Szeged, HU, Hungary, 6725
- Not yet recruiting
- Research Site
-
-
-
-
Andhra Pradesh
-
Guntur, Andhra Pradesh, India, 522001
- Not yet recruiting
- Research Site
-
-
Assam
-
Guwahati, Assam, India, 781032
- Not yet recruiting
- Research Site
-
-
Karnataka
-
Bangalore, Karnataka, India, 560092
- Not yet recruiting
- Research Site
-
Belagavi, Karnataka, India, 590006
- Not yet recruiting
- Research Site
-
Belagavi, Karnataka, India, 590010
- Not yet recruiting
- Research Site
-
-
Kerala
-
Calicut, Kerala, India, 673008
- Not yet recruiting
- Research Site
-
Kochi, Kerala, India, 682041
- Not yet recruiting
- Research Site
-
Thiruvananthapuram, Kerala, India, 695031
- Not yet recruiting
- Research Site
-
-
Madhya Pradesh
-
Indore, Madhya Pradesh, India, 452008
- Not yet recruiting
- Research Site
-
-
Maharashtra
-
Mumbai, Maharashtra, India, 400012
- Not yet recruiting
- Research Site
-
Nagpur, Maharashtra, India, 440010
- Not yet recruiting
- Research Site
-
Pune, Maharashtra, India, 411013
- Not yet recruiting
- Research Site
-
Pune, Maharashtra, India, 411021
- Not yet recruiting
- Research Site
-
-
New Delhi
-
Delhi, New Delhi, India, 110029
- Not yet recruiting
- Research Site
-
-
Rajasthan
-
Jaipur, Rajasthan, India, 302017
- Not yet recruiting
- Research Site
-
-
Tamil Nadu
-
Chennai, Tamil Nadu, India, 600086
- Not yet recruiting
- Research Site
-
Coimbatore, Tamil Nadu, India, 641018
- Not yet recruiting
- Research Site
-
-
Uttar Pradesh
-
Lucknow, Uttar Pradesh, India, 226030
- Not yet recruiting
- Research Site
-
-
West Bengal
-
Kolkata, West Bengal, India, 700020
- Not yet recruiting
- Research Site
-
-
-
-
-
Putrajaya, Malaysia, 62250
- Not yet recruiting
- Research Site
-
-
Negeri Sembilan
-
Seremban, Negeri Sembilan, Malaysia, 70300
- Recruiting
- Research Site
-
-
Perak
-
Seri Manjung, Perak, Malaysia, 32040
- Not yet recruiting
- Research Site
-
-
Selangor
-
Batu Caves, Selangor, Malaysia, 68100
- Withdrawn
- Research Site
-
-
Wilayah Persekutuan Kuala Lump
-
Kuala Lumpur, Wilayah Persekutuan Kuala Lump, Malaysia, 59100
- Not yet recruiting
- Research Site
-
-
-
-
-
Poznan, Poland, 60-354
- Recruiting
- Research Site
-
Warsaw, Poland, 00-124
- Not yet recruiting
- Research Site
-
-
Lublin Voivodeship
-
Lublin, Lublin Voivodeship, Poland, 20-718
- Not yet recruiting
- Research Site
-
-
Malopolska
-
Krakow, Malopolska, Poland, 31-261
- Not yet recruiting
- Research Site
-
-
Masovian Voivodeship
-
Radom, Masovian Voivodeship, Poland, 26-600
- Not yet recruiting
- Research Site
-
-
Podlaskie Voivodeship
-
Bialystok, Podlaskie Voivodeship, Poland, 15-879
- Recruiting
- Research Site
-
-
Silesian Voivodeship
-
Częstochowa, Silesian Voivodeship, Poland, 42-217
- Not yet recruiting
- Research Site
-
-
Łódź Voivodeship
-
Lodz, Łódź Voivodeship, Poland, 90-338
- Recruiting
- Research Site
-
-
Świętokrzyskie Voivodeship
-
Kielce, Świętokrzyskie Voivodeship, Poland, 25-355
- Not yet recruiting
- Research Site
-
-
-
-
-
Adana, Turkey (Türkiye), 01060
- Not yet recruiting
- Research Site
-
Adana, Turkey (Türkiye), 01250
- Not yet recruiting
- Research Site
-
Ankara, Turkey (Türkiye), 06530
- Not yet recruiting
- Research Site
-
Gaziantep, Turkey (Türkiye), 27470
- Not yet recruiting
- Research Site
-
Istanbul, Turkey (Türkiye), 34384
- Not yet recruiting
- Research Site
-
Istanbul, Turkey (Türkiye), 34265
- Not yet recruiting
- Research Site
-
Kayseri, Turkey (Türkiye), 38039
- Not yet recruiting
- Research Site
-
-
Turkey
-
Ankara, Turkey, Turkey (Türkiye), 6100
- Recruiting
- Research Site
-
-
-
-
Arizona
-
Peoria, Arizona, United States, 85382
- Not yet recruiting
- Research Site
-
-
Arkansas
-
Little Rock, Arkansas, United States, 72205
- Recruiting
- Research Site
-
-
California
-
Lincoln, California, United States, 95648
- Recruiting
- Research Site
-
-
Florida
-
Jacksonville, Florida, United States, 32256
- Not yet recruiting
- Research Site
-
Lake City, Florida, United States, 32055
- Recruiting
- Research Site
-
Leesburg, Florida, United States, 34748
- Not yet recruiting
- Research Site
-
Ocoee, Florida, United States, 34761
- Recruiting
- Research Site
-
-
Georgia
-
Decatur, Georgia, United States, 30030
- Recruiting
- Research Site
-
-
Illinois
-
Melrose Park, Illinois, United States, 60160
- Not yet recruiting
- Research Site
-
-
Kansas
-
El Dorado, Kansas, United States, 67042
- Not yet recruiting
- Research Site
-
-
Maryland
-
Potomac, Maryland, United States, 20854
- Recruiting
- Research Site
-
-
Ohio
-
Maumee, Ohio, United States, 43537
- Not yet recruiting
- Research Site
-
-
South Carolina
-
Gaffney, South Carolina, United States, 29340
- Recruiting
- Research Site
-
-
Washington
-
Renton, Washington, United States, 98057
- Recruiting
- Research Site
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Participants must be ≥ 18 years of age at the time of signing the ICF.
- Patients with a diagnosis of T2DM, test- or documentation-confirmed as per World
Health Organization or local diagnostic standards, inadequately managed with:
- Lifestyle management alone, AND/OR
A stable dose of background glucose-lowering medication(s) for T2DM (As specified in the Protocol) for at least 45 days prior to signing the ICF.
- Expresses interest in participating in an ongoing or future T2DM clinical study, is motivated and willing to make themselves available for the duration of the study, and is able to follow study procedures as required.
- Provision of signed and dated written informed consent (As specified in the Protocol) before any study-specific procedures, sampling, or analysis.
Exclusion Criteria:
- Current or planned use of GLP-1 RAs prohibited in ongoing or future T2DM studies evaluating the efficacy and safety of investigational GLP-1 RAs (As specified in the Protocol).
- Diagnosed with Type 1 diabetes mellitus.
- Known pregnancy at the time of visit or having the intention to become pregnant.
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Participants with Type 2 Diabetes
|
The approximate volume of blood required is 2 mL
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient demographics
Time Frame: Visit 1 (Single day)
|
Summary statistics
|
Visit 1 (Single day)
|
|
Medical and surgical history
Time Frame: Visit 1 (Single day)
|
Summary statistics
|
Visit 1 (Single day)
|
|
Concomitant medication
Time Frame: Visit 1 (Single day)
|
Summary statistics
|
Visit 1 (Single day)
|
|
HbA1c levels
Time Frame: Visit 1 (Single day)
|
Summary statistics
|
Visit 1 (Single day)
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Referral to ongoing or future T2DM study.
Time Frame: Visit 1 (Single day)
|
Number of participants with high likelihood of meeting eligibility criteria in ongoing or future T2DM studies, for referral to those studies.
|
Visit 1 (Single day)
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- D7261C00007
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Qualified researchers can request access to anonymized individual patient-level data from AstraZeneca group of companies sponsored clinical trials via the request portal Vivli.org. All requests will be evaluated as per the AZ disclosure commitment: https://astrazenecagrouptrials.pharmacm.com/ST/Submission/Disclosure.
Yes, indicates that AZ are accepting requests for IPD, but this does not mean all requests will be shared.
IPD Sharing Time Frame
IPD Sharing Access Criteria
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.